Clinical Trial Update: Safety and Efficacy of TAK-715 in Subjects With Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 study of TAK-715 in rheumatoid arthritis reports safety and efficacy outcomes; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• TAK-715

Snippet

Sponsor: Takeda | Conditions: Arthritis, Rheumatoid | Phase 2 | Status: COMPLETED